Association of size for gestational age and dehydroepiandrosterone sulfate with cardiometabolic risk in central precocious puberty girls.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 25 12 2022
accepted: 28 04 2023
medline: 12 6 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: epublish

Résumé

The aim of this study was to assess whether size for gestational age and dehydroepiandrosterone sulfate (DHEAS) are associated with cardiometabolic risk in central precocious puberty (CPP) girls. The retrospective study included 443 patients with newly diagnosed CPP. Subjects were categorized by birth weight for gestational age (appropriate [AGA], small [SGA], and large [LGA] for gestational age) and serum DHEAS concentration (high [≥75th percentile] and normal [<75th percentile] DHEAS). Cardiometabolic parameters were examined. Composite cardiometabolic risk (CMR) score was calculated based on BMI, blood pressure, glucose, insulin, triglyceride, and HDL cholesterol. Non-obesity CMR score was computed, omitting the value from BMI. Logistic regression models, general linear models, and partial correlation analyses were used to evaluate associations. Propensity score matching was performed for sensitivity analyses. Overall, 309 patients (69.8%) were born AGA, 80 (18.1%) were born SGA, and 54 (12.2%) were born LGA. Compared with AGA counterparts, CPP girls born SGA were more prone to have elevated HbA1c (adjusted OR = 4.54; 95% CI, 1.43-14.42) and low HDL cholesterol (adjusted OR = 2.33; 95% CI, 1.18-4.61). In contrast, being born LGA was not associated with increased risk for any glucose or lipid derangements. Despite the fact that elevated CMR score was more common among individuals born LGA than AGA (adjusted OR = 1.84; 95% CI, 1.07-4.35), no significant difference was found on non-obesity CMR score (adjusted OR = 0.75; 95% CI, 0.30-1.88). When controlling for age, birth weight SDS, and current BMI-SDS, individuals with high DHEAS exhibited higher HDL cholesterol and apolipoprotein A-1 concentrations and lower triglyceride level and non-obesity CMR score. Furthermore, DHEAS correlated positively with HDL cholesterol and apolipoprotein A-1 and negatively with triglyceride, prominently in girls born SGA, after adjustments for the three abovementioned confounders. Sensitivity analyses corroborated the findings. Among CPP girls, those born SGA were more likely to possess cardiometabolic risk factors compared to their AGA peers. The difference we observed in cardiometabolic risk between individuals born LGA and AGA was driven by BMI. High DHEAS was associated with favorable lipid profile in CPP girls, even in subjects born SGA.

Identifiants

pubmed: 37293501
doi: 10.3389/fendo.2023.1131438
pmc: PMC10244634
doi:

Substances chimiques

Dehydroepiandrosterone Sulfate 57B09Q7FJR
Cholesterol, HDL 0
Apolipoprotein A-I 0
Triglycerides 0
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1131438

Informations de copyright

Copyright © 2023 Zhang, Yu, Yu, Luo, Liang, Hou and Wu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Fertil Steril. 2012 Nov;98(5):1318-25.e1
pubmed: 22835450
J Clin Endocrinol Metab. 2009 Oct;94(10):3696-9
pubmed: 19737922
JAMA Netw Open. 2022 May 2;5(5):e2214379
pubmed: 35622362
Diabetes Care. 2022 Jan 1;45(Suppl 1):S4-S7
pubmed: 34964881
JAMA Netw Open. 2020 Oct 1;3(10):e2015665
pubmed: 33044548
Pediatr Diabetes. 2014 May;15(3):151-61
pubmed: 24754463
PLoS One. 2014 Aug 12;9(8):e104278
pubmed: 25117750
Front Endocrinol (Lausanne). 2022 Jul 28;13:951552
pubmed: 35966072
Clin Epidemiol. 2019 Sep 19;11:873-883
pubmed: 31572017
Diabetol Metab Syndr. 2013 Nov 15;5(1):71
pubmed: 24228769
Obesity (Silver Spring). 2020 Jan;28(1):106-113
pubmed: 31729166
BJOG. 2008 Jun;115(7):886-93
pubmed: 18485168
Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1903-1910
pubmed: 33941428
Transl Pediatr. 2021 Apr;10(4):783-789
pubmed: 34012828
Obes Rev. 2018 Dec;19(12):1688-1699
pubmed: 30223304
Endocr Connect. 2012 Nov 19;2(1):1-10
pubmed: 23781312
Zhonghua Er Ke Za Zhi. 2009 Jul;47(7):487-92
pubmed: 19951507
Eur J Endocrinol. 2011 Aug;165(2):189-207
pubmed: 21622478
Int J Obes (Lond). 2019 Aug;43(8):1568-1577
pubmed: 30886238
J Clin Endocrinol Metab. 2010 Aug;95(8):3736-44
pubmed: 20484471
Cytokine. 2021 Dec;148:155660
pubmed: 34334260
Acta Paediatr. 2017 Jan;106(1):61-66
pubmed: 27743496
Pediatr Res. 2017 Aug;82(2):285-289
pubmed: 28419081
Pediatr Res. 2015 Oct;78(4):457-61
pubmed: 26086641
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Fertil Steril. 2015 Mar;103(3):795-801.e2
pubmed: 25585504
Int J Obes (Lond). 2018 Jan;42(1):20-27
pubmed: 28925411
J Pediatr. 2016 Mar;170:199-205
pubmed: 26706233
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2592-2600
pubmed: 29757399
Clin Endocrinol (Oxf). 2022 Dec;97(6):747-754
pubmed: 35918802
Zhonghua Er Ke Za Zhi. 2009 Jul;47(7):493-8
pubmed: 19951508
J Pediatr. 2017 Mar;182:99-106
pubmed: 28012695
Horm Res Paediatr. 2015;84(6):401-7
pubmed: 26513727
Horm Res Paediatr. 2019;92(6):357-364
pubmed: 32259819
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3349-3359
pubmed: 28911133
Vitam Horm. 2018;108:333-353
pubmed: 30029733
Ann Epidemiol. 2016 Sep;26(9):643-7
pubmed: 27664850
Diabetes Care. 2008 May;31(5):1031-6
pubmed: 18223033
J Pediatr. 1952 Apr;40(4):423-41
pubmed: 14918032
Pediatr Res. 2022 Jun;91(7):1897-1905
pubmed: 34417562
Horm Res Paediatr. 2020;93(3):144-153
pubmed: 32846418
Diabetes Care. 2009 May;32(5):909-14
pubmed: 19196890
JAMA Pediatr. 2020 Apr 1;174(4):e195881
pubmed: 32040143
J Pediatr. 2014 Jan;164(1):78-82
pubmed: 24120018
Clin Endocrinol (Oxf). 2022 Nov;97(5):588-595
pubmed: 35150162
J Clin Endocrinol Metab. 2007 Nov;92(11):4282-5
pubmed: 17698912
Diabetes Care. 2012 Apr;35(4):850-6
pubmed: 22338106
Am J Epidemiol. 1985 Nov;122(5):750-61
pubmed: 4050768
Zhonghua Er Ke Za Zhi. 2015 Jun;53(6):412-8
pubmed: 26310550
Clin Endocrinol (Oxf). 2022 Mar;96(3):419-427
pubmed: 34904249
Cardiovasc Diabetol. 2008 Jun 05;7:17
pubmed: 18534019

Auteurs

Guijiao Zhang (G)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Huan Yu (H)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Shengxu Yu (S)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Xiaoping Luo (X)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Yan Liang (Y)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Ling Hou (L)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Wei Wu (W)

Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH